-
Je něco špatně v tomto záznamu ?
Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice
M. Pohanka, O. Pavlis, H. Svobodova, J. Pikula
Jazyk angličtina Země Slovensko
Typ dokumentu práce podpořená grantem, časopisecké články
NLK
Free Medical Journals
od 2008
PubMed Central
od 2008 do 2019
Europe PubMed Central
od 2008 do 2018
ProQuest Central
od 2008-06-01 do 2020-01-31
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2009-06-19
Nursing & Allied Health Database (ProQuest)
od 2008-06-01 do 2020-01-31
Health & Medicine (ProQuest)
od 2008-06-01 do 2020-01-31
Public Health Database (ProQuest)
od 2008-06-01 do 2021-01-31
Sciendo
od 2009-06-19
ROAD: Directory of Open Access Scholarly Resources
od 2008
- MeSH
- acetylcholin * imunologie toxicita MeSH
- cytokiny účinky léků MeSH
- Francisella tularensis patogenita MeSH
- imunomodulace MeSH
- myši inbrední BALB C MeSH
- neostigmin * imunologie toxicita MeSH
- parasympatický nervový systém účinky léků MeSH
- tularemie * imunologie komplikace mortalita MeSH
- výzkum MeSH
- zánět imunologie mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected mice exposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.
Centre of Biological Defense Techonin Czech Republic
Faculty of Military Health Sciences University of Defense Hradec Kralove Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13016099
- 003
- CZ-PrNML
- 005
- 20200430092007.0
- 007
- ta
- 008
- 130424s2012 xo d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2478/v10102-012-0004-7 $2 doi
- 035 __
- $a (PubMed)22783145
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic $7 hka2010563580
- 245 10
- $a Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice / $c M. Pohanka, O. Pavlis, H. Svobodova, J. Pikula
- 520 9_
- $a The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected mice exposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.
- 650 12
- $a neostigmin $x imunologie $x toxicita $7 D009388
- 650 _2
- $a Francisella tularensis $x patogenita $7 D005604
- 650 12
- $a tularemie $x imunologie $x komplikace $x mortalita $7 D014406
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a acetylcholin $x imunologie $x toxicita $7 D000109
- 650 _2
- $a parasympatický nervový systém $x účinky léků $7 D010275
- 650 _2
- $a zánět $x imunologie $x mikrobiologie $7 D007249
- 650 _2
- $a imunomodulace $7 D056747
- 650 _2
- $a cytokiny $x účinky léků $7 D016207
- 650 _2
- $a výzkum $7 D012106
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pavliš, Oto $7 xx0135660 $u Centre of Biological Defense, Techonin, Czech Republic
- 700 1_
- $a Svobodová, Hana $u Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic $7 _AN065759
- 700 1_
- $a Pikula, Jiří, $u Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic $d 1967- $7 mzk2003196544
- 773 0_
- $w MED00174076 $t Interdisciplinary toxicology $x 1337-9569 $g Roč. 5, č. 1 (2012), s. 21-24
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22783145 $y Pubmed
- 910 __
- $a ABA008 $b B 2642 $c 547 $y a $z 0
- 990 __
- $a 20130424 $b ABA008
- 991 __
- $a 20200430092002 $b ABA008
- 999 __
- $a ok $b bmc $g 979300 $s 814420
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 5 $c 1 $d 21-24 $i 1337-9569 $m Interdisciplinary toxicology $n Interdiscip. toxicol. $x MED00174076
- LZP __
- $c NLK185 $d 20180214 $b NLK118 $a Pubmed-20130424